# Deutsche Bank Shifts Novartis From Hold to Sell in Q3 Review

By Enna Lee

Canonical URL: https://www.tokenpost.com/news/investing/45060
Published: 2026-10-30T19:30:10.000Z
Updated: 2026-10-30T19:30:10.000Z
Section: Investing

> The downgrade came as the bank reviewed Novartis’ third-quarter 2026 results.

Deutsche Bank shifted its Novartis recommendation to Sell, replacing Hold, on Friday, Oct. 30, as it reviewed the Swiss drugmaker’s third-quarter 2026 results.

The rating decision was part of Deutsche Bank’s review of the company’s Q3 results.